Novartis AG Oncology Update Call Transcript
Good morning and good afternoon, and welcome to the Novartis Oncology Update. (Operator Instructions) And the conference is being recorded. (Operator Instructions) A recording of the conference call, including the Q&A session, will be available on our website shortly after the call ends. (Operator Instructions)
With that, I would like to hand over to Mr. Samir Shah, Head of Investor Relations. Please go ahead, sir.
Thank you and good morning and good afternoon, everybody. Thank you so much for taking the time to join us today. We appreciate it's a really busy time especially today with the various investor-related calls. It's my pleasure to have with us today, as we go through the key highlights from ASCO, Susanne Schaffert, who's the President of Novartis Oncology; Alice Shaw, Global Head of Translational Clinical Oncology at the Novartis Institute of Biomedical Research; Sidonie Daffner, who's the President of Radioligand Therapies; and Jeff Legos, the Global Head of Oncology Development within Novartis
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
